Table 6 Univariable and multivariable analyses of clinical variables influencing relapse in CD

 3–9 y vs 0–2 y

0.25

0.14–0.48

< 0.01

0.26

0.13–0.53

< 0.01

 10–16 y vs 0–2 y

0.20

0.11–0.36

< 0.01

0.23

0.12–0.44

< 0.01

 female vs male

0.84

0.52–1.36

0.47

 L2 vs L1

2.18

0.98–4.84

0.06

 L3 vs L1

1.29

0.61–2.77

0.51

 L4 vs no L4

0.89

0.54–1.46

0.64

 Perianal disease, yes vs no

1.59

1.00–2.53

0.048

1.13

0.68–1.88

0.63

 Behaviour B2 vs not

1.04

0.66–1.64

0.87

 Behaviour B3 vs not

2.08

1.15–3.77

0.02

1.96

1.01–3.81

0.046

 Weight < -2SD vs not

1.71

1.04–2.82

0.04

0.96

0.54–1.69

0.88

 Growth impairment vs not

1.31

0. 83–2.09

0.25

 Top-down treatment vs not

0.69

0.40–1.21

0.20

 Steroid dependency vs not

2.26

1.40–3.64

< 0.01

1.88

1.16–3.06

0.01